The Effects of Aprotinin on Outcomes in Patients Undergoing Cardiopulmonary Bypass
YUAN Lin-hui,TANG Yan-hua,LI Chang,ZHU Xiao-hong,MA Chang-hua,XU Guo-hai
DOI: https://doi.org/10.3969/j.issn.1000-2294.2010.03.019
2010-01-01
Abstract:Objective To investigate the effect and the safety of aprotinin on outcomes in patients undergoing cardiopulmonary bypass.Methods Retrospective analysis the patients who underwent cardiopulmonary bypass during one year before and after the date,aprotinin was suspended in China,Dec 19,2007.Aprotinin group(n=360)was defined as operations from Dec 19,2006 to Dec 18,2007,aprotinin was used in the operations.Control group(n=360)was defined as operations from Dec 19,2007 to Dec 18,2008.aprotinin was not used.Postoperative outcomes between the two groups were compared,including extracorporeal circulation time,aortic cross-clamping time,blood loss,blood transfusion requirement,ventilating time,oxygen index of 24 hours postoperation,reoperation rate,in-hospital mortality,incidence rate of renal inadequacy,low cardiac output syndrome,prolonged extubation and severe pulmonary infection.Results There were no differences between the two groups for the operation types,extracorporeal circulation time,aortic cross-clamping time,incidence rate of renal inadequacy,low cardiac output syndrome,and in-hospital mortality(all P>0.05).As compared with the control group,aprotinin group had lower blood loss,blood transfusion requirement,ventilating time,reoperation rate,incidence rate of prolonged extubation and severe pulmonary infection(all P<0.05);And had a higher oxygen index of 24 hours postoperation(P<0.05).Conclusion Application of aprotinin is effect and the safety,could reduce blood loss and transfusion requirement,and provided a protective effect on the lungs.It did not increase the risk of in-hospital mortality and morbidity.We suggest whether stopping the ues of aprotinin in China need further studies.